Stockscreener 앱 받기
1.76
1.15%
0.02
시간 외 거래:
1.75
-0.01
-0.57%
Gain Therapeutics Inc 주식(GANX)의 최신 뉴스
What drives Gain Therapeutics Inc.’s stock priceGap Down & Verified Short-Term Plans - 강소기업뉴스
What are Gain Therapeutics Inc.’s growth leversBreakout Watch & Expert Verified Movement Alerts - 뉴스영
Forecasting Gain Therapeutics Inc. price range with options dataJuly 2025 Breakouts & Safe Swing Trade Setups - Newser
Using Ichimoku Cloud for Gain Therapeutics Inc. technicalsLong Setup & Consistent Return Strategy Ideas - Newser
Ranking Gain Therapeutics Inc. among high performing stocks via toolsNew Guidance & Daily Price Action Insights - Newser
How to use a screener to detect Gain Therapeutics Inc. breakoutsTrade Signal Summary & High Accuracy Trade Alerts - Newser
Gain Therapeutics Inc. recovery potential after sell offJuly 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
Live market analysis of Gain Therapeutics Inc.2025 Earnings Surprises & Safe Entry Momentum Tips - Newser
Is a relief rally coming for Gain Therapeutics Inc. holdersJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Is now a turning point for Gain Therapeutics Inc.July 2025 News Drivers & High Conviction Buy Zone Picks - Newser
Gain Therapeutics Inc. stock volume spike explainedJuly 2025 Action & Daily Profit Focused Stock Screening - Newser
Is this a good reentry point in Gain Therapeutics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
What indicators show strength in Gain Therapeutics Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
Will Gain Therapeutics Inc. benefit from seasonalityJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - خودرو بانک
Visualizing Gain Therapeutics Inc. stock with heatmapsJuly 2025 Pullbacks & Daily Market Momentum Tracking - Newser
T1 Energy Inc. shares rise 3.78% premarket after Gain Therapeutics extended Phase 1b trial of GT-02287. - AInvest
Gain Therapeutics: A High-Conviction Biotech Play in Parkinson’s Disease Innovation - AInvest
Price action breakdown for Gain Therapeutics Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investorsJobs Report & Accurate Technical Buy Alerts - Newser
What’s next for Gain Therapeutics Inc. stock priceEarnings Summary Report & Weekly High Potential Stock Alerts - Newser
Gain Therapeutics Inc.’s volatility index tracking explainedEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
What data driven models say about Gain Therapeutics Inc.’s futureWatch List & Stepwise Trade Signal Guides - Newser
Does Gain Therapeutics Inc. have declining or rising EPSJuly 2025 Trade Ideas & Weekly High Conviction Ideas - خودرو بانک
Gain Therapeutics extends Phase 1b Parkinson’s drug trial to 12 months - Investing.com Australia
12-Month Extension Approved: Gain Therapeutics' Parkinson's Drug Trial Shows Promise in Safety Review - Stock Titan
Is Gain Therapeutics Inc. a momentum stockWeekly Stock Recap & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Gain Therapeutics Inc. stock a good pick for beginnersJuly 2025 PreEarnings & High Yield Equity Trading Tips - خودرو بانک
What the charts say about Gain Therapeutics Inc. todayMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
Developing predictive dashboards with Gain Therapeutics Inc. data2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
1.40%
자본화:
|
볼륨(24시간):